UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 179

Sortiert nach

Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program

Annals of oncology, 2017-11, Vol.28 (11), p.2715-2724

2017

Link zum Volltext

Verfügbarkeit prüfen

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project

Lung cancer (Amsterdam, Netherlands), 2021-01, Vol.151, p.69-75

2021

Link zum Volltext

Verfügbarkeit prüfen

Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors

Lung cancer (Amsterdam, Netherlands), 2023-08, Vol.182, p.107280-107280, Article 107280

2023

Link zum Volltext

Verfügbarkeit prüfen

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

Annals of oncology, 2023-10, Vol.34 (10), p.920-933

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)

Annals of oncology, 2005-01, Vol.16 (1), p.90-96

2005

Link zum Volltext

Verfügbarkeit prüfen

Caractéristiques cliniques des patients asthmatiques sévères : étude FASE-CPHG

Revue française d'allergologie (2009), 2022-04, Vol.62 (3), p.357-357

2022

Link zum Volltext

Verfügbarkeit prüfen

Comment effectuer des comparaisons indirectes ajustées par appariement (MAIC) avec imputations multiples des données manquantes et dans un contexte de faibles échantillons ? Une méthodologie illustrée dans le cancer du poumon à partir d'essais cliniques agrégés et de la cohorte nationale ESME-AMLC

Revue d'épidémiologie et de santé publique, 2022-11, Vol.70, p.S266-S267

2022

Link zum Volltext

Verfügbarkeit prüfen

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial

Annals of oncology, 2017-05, Vol.28 (5), p.1078-1083

2017

Link zum Volltext

Verfügbarkeit prüfen

Cerebral air embolism: A rare complication of flexible fiberoptic bronchoscopy

Revue des maladies respiratoires, 2020-10, Vol.37 (8), p.662

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-world treatment patterns, clinical practice and outcomes for locally advanced, non resectable, non-small cell lung cancer from the French ESME Lung database

Annals of oncology, 2019-04, Vol.30, p.ii34-ii34

2019

Link zum Volltext

Verfügbarkeit prüfen

EVIDENS: An observational study of nivolumab-treated patients in advanced non-small cell lung cancer (NSCLC) in a real-world setting: Initial results on 1394 patients

Annals of oncology, 2018-10, Vol.29, p.viii532-viii532

2018

Link zum Volltext

Verfügbarkeit prüfen

Guide for follow-up of patients with SARS-CoV-2 pneumonia. Management proposals developed by the French-language Respiratory Medicine Society. Version of 10 May 2020

Revue des maladies respiratoires, 2020-06, Vol.37 (6), p.505

2020

Link zum Volltext

Verfügbarkeit prüfen

Guide for management of patients with possible respiratory sequelae after a SARS-CoV-2 pneumonia. Support proposals developed by the French-speaking Respiratory Medicine Society. Version of 10 November 2020

Revue des maladies respiratoires, 2021-01, Vol.38 (1), p.114

2021

Link zum Volltext

Verfügbarkeit prüfen

Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients

Respiratory medicine and research, 2020-03, Vol.77, p.46-54

2020

Link zum Volltext

Verfügbarkeit prüfen

Sensibilisation allergénique et asthme sévère en France : résultats de l’étude FASE-CPHG

Revue française d'allergologie (2009), 2023-03, Vol.63 (2), p.103278, Article 103278

2023

Link zum Volltext

Verfügbarkeit prüfen

Severe adult asthma and treatment adherence: Results of the FASE-CPHG study

Revue des maladies respiratoires, 2021-12, Vol.38 (10), p.962

2021

Link zum Volltext

Verfügbarkeit prüfen

Analyse finale de l’étude EVIDENS par région française : survie et tolérance en vie réelle à 3 ans des patients atteints d’un cancer bronchique non à petites cellules (CBNPC) traités par nivolumab

Revue des maladies respiratoires actualités, 2023-01, Vol.15 (1), p.130

2023

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study

Annals of oncology, 2019-04, Vol.30, p.ii48-ii48

2019

Link zum Volltext

Verfügbarkeit prüfen

Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): IFCT-1201 MODEL randomised phase III trial

Annals of oncology, 2018-10, Vol.29, p.viii744-viii745

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular heterogeneity assessment by NGS in non-small cell lung cancer (NSCLC) harboring EGFR mutations: Results of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France study

Annals of oncology, 2018-10, Vol.29, p.viii39-viii40

2018

Link zum Volltext

Verfügbarkeit prüfen

French practical guidelines for the diagnosis and management of IPF - 2021 update, short version

Revue des maladies respiratoires, 2022-03, Vol.39 (3), p.275

2022

Link zum Volltext

Verfügbarkeit prüfen

Physical activity in severe asthma: Results of the FASE-CPHG Study

Revue des maladies respiratoires, 2020-04, Vol.37 (4), p.320

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized Study of Maintenance Vinorelbine in Responders With Advanced Non–Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2005-04, Vol.97 (7), p.499-506

2005

Link zum Volltext

Verfügbarkeit prüfen

Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study

Respiratory medicine and research, 2021-11, Vol.80, p.100795-100795, Article 100795

2021

Link zum Volltext

Verfügbarkeit prüfen

Metastatic NSCLC: Clinical, molecular, and therapeutic factors associated with long-term survival

Respiratory medicine and research, 2019-11, Vol.76, p.38-44

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(156)

Publikationsform

Artikel
(179)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(52)
Life Sciences & Biomedicine
(48)
Science & Technology
(48)
Male
(36)
Female
(32)
Adult
(29)
Aged
(28)
Middle Aged
(28)
Respiratory System
(28)
Lung Neoplasms - Drug Therapy
(19)
Oncology
(19)
Aged, 80 And Over
(16)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(15)
Biological And Medical Sciences
(13)
Lung Neoplasms - Pathology
(13)
Medical Sciences
(13)
Life Sciences
(12)
Carcinoma, Non-Small-Cell Lung - Pathology
(11)
Lung Cancer
(11)
Cancer
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project

Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)

Caractéristiques cliniques des patients asthmatiques sévères : étude FASE-CPHG

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial

Cerebral air embolism: A rare complication of flexible fiberoptic bronchoscopy

Real-world treatment patterns, clinical practice and outcomes for locally advanced, non resectable, non-small cell lung cancer from the French ESME Lung database

EVIDENS: An observational study of nivolumab-treated patients in advanced non-small cell lung cancer (NSCLC) in a real-world setting: Initial results on 1394 patients

Guide for follow-up of patients with SARS-CoV-2 pneumonia. Management proposals developed by the French-language Respiratory Medicine Society. Version of 10 May 2020

Guide for management of patients with possible respiratory sequelae after a SARS-CoV-2 pneumonia. Support proposals developed by the French-speaking Respiratory Medicine Society. Version of 10 November 2020

Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients

Sensibilisation allergénique et asthme sévère en France : résultats de l’étude FASE-CPHG

Severe adult asthma and treatment adherence: Results of the FASE-CPHG study

Analyse finale de l’étude EVIDENS par région française : survie et tolérance en vie réelle à 3 ans des patients atteints d’un cancer bronchique non à petites cellules (CBNPC) traités par nivolumab

Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study

Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): IFCT-1201 MODEL randomised phase III trial

Molecular heterogeneity assessment by NGS in non-small cell lung cancer (NSCLC) harboring EGFR mutations: Results of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France study

French practical guidelines for the diagnosis and management of IPF - 2021 update, short version

Physical activity in severe asthma: Results of the FASE-CPHG Study

Randomized Study of Maintenance Vinorelbine in Responders With Advanced Non–Small-Cell Lung Cancer

Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study

Metastatic NSCLC: Clinical, molecular, and therapeutic factors associated with long-term survival

Suchergebnisse filtern